Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 10, 2012 - Issue 6
Submit an article Journal homepage
239
Views
9
CrossRef citations to date
0
Altmetric
Theme: Hyper- & Hypo-tension - Review

Treatment of hypertension in diabetes: what is the best therapeutic option?

Tonje A Aksnes Department of Cardiology, Oslo University Hospital, Ullevål, Oslo, Norway. [email protected]; Department of Cardiology, Oslo University Hospital, Ullevål, Oslo, Norway. [email protected]
,
Sigrid N Skårn Department of Acute Medicine, Section of Cardiovascular and Renal Research, Oslo University Hospital, Ullevål, Oslo, Norway; Department of Acute Medicine, Section of Cardiovascular and Renal Research, Oslo University Hospital, Ullevål, Oslo, Norway
&
Sverre E Kjeldsen Department of Cardiology, Oslo University Hospital, Ullevål, Oslo, Norway. [email protected]; Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA; Department of Cardiology, Oslo University Hospital, Ullevål, Oslo, Norway. [email protected]; Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA
Pages 727-734 | Published online: 10 Jan 2014

References

  • Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27(5), 1047–1053 (2004).
  • Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16(2), 434–444 (1993).
  • Sarwar N, Gao P, Seshasai SR et al.; Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375(9733), 2215–2222 (2010).
  • Hu G, Jousilahti P, Tuomilehto J. Joint effects of history of hypertension at baseline and Type 2 diabetes at baseline and during follow-up on the risk of coronary heart disease. Eur. Heart J. 28(24), 3059–3066 (2007).
  • Norhammar A, Malmberg K, Diderholm E et al. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J. Am. Coll. Cardiol. 43(4), 585–591 (2004).
  • Malmberg K, Rydén L, Wedel H et al.; DIGAMI 2 Investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur. Heart J. 26(7), 650–661 (2005).
  • Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with Type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339(4), 229–234 (1998).
  • Chen G, McAlister FA, Walker RL, Hemmelgarn BR, Campbell NR. Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure. Hypertension 57(5), 891–897 (2011).
  • Mancia G, De Backer G, Dominiczak A et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 28(12), 1462–1536 (2007).
  • Chobanian AV, Bakris GL, Black HR et al.; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute National High Blood Pressure Education Program Coordinating Committee: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42(6), 1206–1252 (2003).
  • Mancia G, Laurent S, Agabiti-Rosei E et al.; European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J. Hypertens. 27(11), 2121–2158 (2009).
  • Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351(9118), 1755–1762 (1998).
  • Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Long-term follow-up after tight control of blood pressure in Type 2 diabetes. N. Engl. J. Med. 359(15), 1565–1576 (2008).
  • Cushman WC, Evans GW, Byington RP et al.; ACCORD Study Group. Effects of intensive blood-pressure control in Type 2 diabetes mellitus. N. Engl. J. Med. 362(17), 1575–1585 (2010).
  • Redon J, Mancia G, Sleight P et al.; ONTARGET Investigators. Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial). J. Am. Coll. Cardiol. 59(1), 74–83 (2012).
  • Bangalore S, Kumar S, Lobach I, Messerli FH. Blood pressure targets in subjects with Type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials. Circulation 123(24), 2799–2819 (2011).
  • Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care 33(2), 434–441 (2010).
  • Cutler JA, Follmann D, Allender PS. Randomized trials of sodium reduction: an overview. Am. J. Clin. Nutr. 65(Suppl. 2), 643S–651S (1997).
  • Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann. Intern. Med. 136(7), 493–503 (2002).
  • ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288(23), 2981–2997 (2002).
  • Turnbull F, Neal B, Algert C et al.; Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch. Intern. Med. 165(12), 1410–1419 (2005).
  • McFarlane SI, Castro J, Kaur J et al. Control of blood pressure and other cardiovascular risk factors at different practice settings: outcomes of care provided to diabetic women compared to men. J. Clin. Hypertens. (Greenwich) 7(2), 73–80 (2005).
  • Suh DC, Kim CM, Choi IS, Plauschinat CA, Barone JA. Trends in blood pressure control and treatment among Type 2 diabetes with comorbid hypertension in the United States: 1988–2004. J. Hypertens. 27(9), 1908–1916 (2009).
  • Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 369(9557), 201–207 (2007).
  • Lindholm LH, Ibsen H, Dahlöf B et al.; LIFE Study Group. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359(9311), 1004–1010 (2002).
  • Zanchetti A, Julius S, Kjeldsen S et al. Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial. J. Hypertens. 24(11), 2163–2168 (2006).
  • Yusuf S, Teo KK, Pogue J et al.; ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N. Engl. J. Med. 358(15), 1547–1559 (2008).
  • Ostergren J, Poulter NR, Sever PS et al.; ASCOT investigators. The Anglo–Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with Type II diabetes. J. Hypertens. 26(11), 2103–2111 (2008).
  • Whelton PK, Barzilay J, Cushman WC et al.; ALLHAT Collaborative Research Group. Clinical outcomes in antihypertensive treatment of Type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch. Intern. Med. 165(12), 1401–1409 (2005).
  • Beckett NS, Peters R, Fletcher AE et al.; HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N. Engl. J. Med. 358(18), 1887–1898 (2008).
  • Grossman E, Messerli FH. Management of blood pressure in patients with diabetes. Am. J. Hypertens. 24(8), 863–875 (2011).
  • Weber MA, Julius S, Kjeldsen SE et al. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. Lancet 363(9426), 2049–2051 (2004).
  • Corrao G, Nicotra F, Parodi A et al. Cardiovascular protection by initial and subsequent combination of antihypertensive drugs in daily life practice. Hypertension 58(4), 566–572 (2011).
  • Weber MA, Bakris GL, Dahlöf B et al. Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk. Blood Press. 16(1), 13–19 (2007).
  • Weber MA, Bakris GL, Jamerson K et al.; ACCOMPLISH Investigators. Cardiovascular events during differing hypertension therapies in patients with diabetes. J. Am. Coll. Cardiol. 56(1), 77–85 (2010).
  • Patel A, MacMahon S, Chalmers J et al.; ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with Type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 370(9590), 829–840 (2007).
  • Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 414(6865), 782–787 (2001).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.